The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells
- PMID: 12457876
- DOI: 10.1016/s0041-0101(02)00205-2
The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells
Similar articles
-
The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.Int J Med Microbiol. 2004 Apr;293(7-8):571-6. doi: 10.1078/1438-4221-00291. Int J Med Microbiol. 2004. PMID: 15149033 Review.
-
Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.Infect Immun. 2006 Apr;74(4):2277-85. doi: 10.1128/IAI.74.4.2277-2285.2006. Infect Immun. 2006. PMID: 16552058 Free PMC article.
-
Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites.Infect Immun. 2000 Jan;68(1):247-56. doi: 10.1128/IAI.68.1.247-256.2000. Infect Immun. 2000. PMID: 10603395 Free PMC article.
-
Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.Infect Immun. 2000 Jul;68(7):3867-72. doi: 10.1128/IAI.68.7.3867-3872.2000. Infect Immun. 2000. PMID: 10858196 Free PMC article.
-
Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Vaccine Development and Other Biotechnological Purposes.Toxins (Basel). 2021 Jan 22;13(2):83. doi: 10.3390/toxins13020083. Toxins (Basel). 2021. PMID: 33499260 Free PMC article. Review.
Cited by
-
Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy.Toxins (Basel). 2018 Jul 20;10(7):302. doi: 10.3390/toxins10070302. Toxins (Basel). 2018. PMID: 30037010 Free PMC article. Review.
-
Adjuvants for allergy vaccines.Hum Vaccin Immunother. 2012 Oct;8(10):1492-8. doi: 10.4161/hv.21688. Epub 2012 Oct 1. Hum Vaccin Immunother. 2012. PMID: 23095872 Free PMC article. Review.
-
Prime/boost immunotherapy of HPV16-induced tumors with E7 protein delivered by Bordetella adenylate cyclase and modified vaccinia virus Ankara.Cancer Immunol Immunother. 2006 Jan;55(1):39-46. doi: 10.1007/s00262-005-0700-7. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15926077 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources